v3.26.1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
ATM Offering Program
Common Stock
Common Stock
ATM Offering Program
Additional Paid-in Capital
Additional Paid-in Capital
ATM Offering Program
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Stockholders' Equity, beginning balances at Dec. 31, 2024 $ 510,606   $ 5   $ 1,086,567   $ 229 $ (576,195)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2024     45,793,942          
Issuance of common stock upon exercise of stock options and vesting of RSUs (in shares)     22,235          
Issuance of common stock upon exercise of equity warrants (in shares)     508,465          
Stock-based compensation expense 6,986       6,986      
Net unrealized gain (loss) on marketable securities 103           103  
Net loss (47,972)             (47,972)
Stockholders' Equity, ending balances at Mar. 31, 2025 469,723   $ 5   1,093,553   332 (624,167)
Stockholders' Equity, ending balances (in shares) at Mar. 31, 2025     46,324,642          
Stockholders' Equity, beginning balances at Dec. 31, 2024 510,606   $ 5   1,086,567   229 (576,195)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2024     45,793,942          
Net unrealized gain (loss) on marketable securities 108              
Net loss (102,630)              
Stockholders' Equity, ending balances at Jun. 30, 2025 420,890   $ 5   1,099,373   337 (678,825)
Stockholders' Equity, ending balances (in shares) at Jun. 30, 2025     46,700,242          
Stockholders' Equity, beginning balances at Dec. 31, 2024 510,606   $ 5   1,086,567   229 (576,195)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2024     45,793,942          
Stockholders' Equity, ending balances at Dec. 31, 2025 505,664   $ 6   1,221,235   727 (716,304)
Stockholders' Equity, ending balances (in shares) at Dec. 31, 2025     57,607,874          
Stockholders' Equity, beginning balances at Mar. 31, 2025 469,723   $ 5   1,093,553   332 (624,167)
Stockholders' Equity, beginning balances (in shares) at Mar. 31, 2025     46,324,642          
Issuance of common stock upon exercise of stock options and vesting of RSUs 2       2      
Issuance of common stock upon exercise of stock options and vesting of RSUs (in shares)     49,791          
Issuance of common stock - 2020 ESPP 860       860      
Issuance of common stock - 2020 ESPP (in shares)     323,290          
Issuance of common stock upon exercise of equity warrants (in shares)     2,519          
Stock-based compensation expense 4,958       4,958      
Net unrealized gain (loss) on marketable securities 5           5  
Net loss (54,658)             (54,658)
Stockholders' Equity, ending balances at Jun. 30, 2025 420,890   $ 5   1,099,373   337 (678,825)
Stockholders' Equity, ending balances (in shares) at Jun. 30, 2025     46,700,242          
Stockholders' Equity, beginning balances at Dec. 31, 2025 505,664   $ 6   1,221,235   727 (716,304)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2025     57,607,874          
Issuance of common stock upon exercise of stock options and vesting of RSUs 1,674       1,674      
Issuance of common stock upon exercise of stock options and vesting of RSUs (in shares)     251,629          
Issuance of common stock upon ATM offering, net of issuance costs   $ 9,712       $ 9,712    
Issuance of common stock upon ATM offering, net of issuance costs (in shares)       1,012,145        
Exchange of common stock for pre-funded warrants     $ (1)   1      
Exchange of common stock for pre-funded warrants (in shares)     (6,600,000)          
Stock-based compensation expense 4,453       4,453      
Net unrealized gain (loss) on marketable securities (907)           (907)  
Net loss (68,760)             (68,760)
Stockholders' Equity, ending balances at Mar. 31, 2026 451,836   $ 5   1,237,075   (180) (785,064)
Stockholders' Equity, ending balances (in shares) at Mar. 31, 2026     52,271,648          
Stockholders' Equity, beginning balances at Dec. 31, 2025 505,664   $ 6   1,221,235   727 (716,304)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2025     57,607,874          
Net unrealized gain (loss) on marketable securities (1,173)              
Net loss (141,696)              
Stockholders' Equity, ending balances at Jun. 30, 2026 407,659   $ 6   1,266,099   (446) (858,000)
Stockholders' Equity, ending balances (in shares) at Jun. 30, 2026     55,214,097          
Stockholders' Equity, beginning balances at Mar. 31, 2026 451,836   $ 5   1,237,075   (180) (785,064)
Stockholders' Equity, beginning balances (in shares) at Mar. 31, 2026     52,271,648          
Issuance of common stock upon exercise of stock options and vesting of RSUs 111       111      
Issuance of common stock upon exercise of stock options and vesting of RSUs (in shares)     67,640          
Issuance of common stock - 2020 ESPP 1,125       1,125      
Issuance of common stock - 2020 ESPP (in shares)     368,482          
Issuance of common stock upon ATM offering, net of issuance costs   $ 21,905   $ 1   $ 21,904    
Issuance of common stock upon ATM offering, net of issuance costs (in shares)       2,506,327        
Stock-based compensation expense 5,884       5,884      
Net unrealized gain (loss) on marketable securities (266)           (266)  
Net loss (72,936)             (72,936)
Stockholders' Equity, ending balances at Jun. 30, 2026 $ 407,659   $ 6   $ 1,266,099   $ (446) $ (858,000)
Stockholders' Equity, ending balances (in shares) at Jun. 30, 2026     55,214,097